Sexual behavior of women taking low-dose oral contraceptive containing 15 μg ethinylestradiol/60 μg gestodene

被引:79
作者
Caruso, S
Agnello, C
Intelisano, G
Farina, M
Di Mari, L
Cianci, A
机构
[1] Univ Catania, Dept Microbiol Sci & Gynaecol Sci, I-95124 Catania, Italy
[2] Univ Catania, Res Grp Sexol, I-95124 Catania, Italy
关键词
ethinylestradiol; gestodene; low-dose oral contraceptives; sexual arousal; sexual behavior; sexual desire;
D O I
10.1016/j.contraception.2003.11.001
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The objective of this prospective study was to assess the effects of a low-dose oral contraceptive (OC) containing 15 mug ethinylestradiol and 60 mug gestodene on sexuality. Forty-eight healthy volunteers (age range, 18-35 years), having regular menstrual cycles with ovulation, participated in the study. Sexual behavior was assessed using the self-administered Personal Experience Questionnaire, at baseline, and at 3, 6 and 9 months of pill use. Women reported decreased sexual desire (p < 0.005) and sexual activity (p < 0.05) at the 9th month of pill use, and diminished sexual arousal at the 3rd month of pill intake (p < 0.05), with respect to baseline. The frequency of orgasm did not change during OC use (p = NS). Moreover, sexual enjoyment was worse at the 3rd, 6th and 9th month with respect to baseline (p < 0.001). The low dose of ethinylestradiol could cause decreased vaginal lubrication, and diminished sexual arousal could be due to hypoandrogenism. Women may expect increased sexual performance when they take the pill, as compared to before starting contraception. Consequently, they could have an unexpected effect with pill use, though sexuality may remain the same. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:237 / 240
页数:4
相关论文
共 29 条
[1]   ORAL-CONTRACEPTIVES, ANDROGENS, AND THE SEXUALITY OF YOUNG-WOMEN - .2. THE ROLE OF ANDROGENS [J].
BANCROFT, J ;
SHERWIN, BB ;
ALEXANDER, GM ;
DAVIDSON, DW ;
WALKER, A .
ARCHIVES OF SEXUAL BEHAVIOR, 1991, 20 (02) :121-135
[2]   Report of the international consensus development conference on female sexual dysfunction: Definitions and classifications [J].
Basson, R ;
Berman, J ;
Burnett, A ;
Derogatis, L ;
Ferguson, D ;
Fourcroy, J ;
Goldstein, I ;
Graziottin, A ;
Heiman, J ;
Laan, E ;
Leiblum, S ;
Padma-Nathan, H ;
Rosen, R ;
Segraves, K ;
Segraves, RT ;
Shabsigh, R ;
Sipski, M ;
Wagner, G ;
Whipple, B .
JOURNAL OF UROLOGY, 2000, 163 (03) :888-893
[3]  
Borgelt-Hansen L, 2001, J Am Pharm Assoc (Wash), V41, P875
[4]   Triphasic oral contraceptives: review and comparison of various regimens [J].
Cedars, MI .
FERTILITY AND STERILITY, 2002, 77 (01) :1-14
[5]   Changes in androgens during treatment with four low-dose contraceptives [J].
Coenen, CMH ;
Thomas, CMG ;
Borm, GF ;
Hollanders, JMG ;
Rolland, R .
CONTRACEPTION, 1996, 53 (03) :171-176
[6]  
CULLBERG G, 1985, ACTA OBSTET GYN SCAN, P1
[7]   Hormone receptors and sexuality in the human female [J].
DeCherney, AH .
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2000, 9 :S9-S13
[8]  
Dei M, 1997, Eur J Contracept Reprod Health Care, V2, P253
[9]   Factors influencing women's satisfaction with birth control methods [J].
den Tonkelaar, I ;
Oddens, BJ .
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2001, 6 (03) :153-158
[10]  
Dennerstein L, 1977, Aust Fam Physician, VSuppl, P19